In a regulatory filing, Protalix disclosed that its director Aharon Schwartz bought 110K shares of common stock on January 3 in a total transaction size of $155.8K. Shares are up 4.9% afterhours at $1.50.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PLX:
- Protalix to voluntarily delist common stock from Tel Aviv Stock Exchange
- Biotech Alert: Searches spiking for these stocks today
- Protalix to hold a KOL webcast
- Protalix, Chiesi Global Rare Diseases announce FDA acceptance of PRX-102 BLA
- Protalix BioTherapeutics Reports Third Quarter 2022 Financial and Business Results
